EICHOR
● Active Not Recruiting
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56
Condition: Wet Age Related Macular Degeneration · wAMD · Sponsor: EyePoint Pharmaceuticals, Inc.
About this study
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (113)
| Associated Retina Consultans | Gilbert, Arizona, United States | — |
| Associated Retina Consultants - Phoenix | Phoenix, Arizona, United States | — |
| Phoenix Retina Clinical Trials, LLC | Phoenix, Arizona, United States | — |
| Retina Macula Institute of Arizona | Scottsdale, Arizona, United States | — |
| Win Retina | Arcadia, California, United States | — |
| Doctor Retina, PC | Beverly Hills, California, United States | — |
| The Retina Partners | Encino, California, United States | — |
| RCOC Clinical Research Institute Inc. | Fullerton, California, United States | — |
| Global Research Management, Inc. | Glendale, California, United States | — |
| Atlantis Eyecare | Huntington Beach, California, United States | — |
| South Coast Retina Center | Long Beach, California, United States | — |
| Retinal Consultants Medical Group | Modesto, California, United States | — |
+ 101 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06683742